Clinicopathological variables | Tumor ETV1 expression | P Value | Tumor ETV1 expression | P Value | |||
---|---|---|---|---|---|---|---|
Negative (n = 151) | Positive (n = 109) | Negative (n = 154) | Positive (n = 126) | ||||
Age | Â | 52.11 | 51.77 | 0.411 | 50.57 | 51.51 | 0.351 |
(11.915) | (10.417) | Â | (10.053) | (9.743) | Â | ||
Sex | female | 31 | 18 | 0.428 | 19 | 25 | 0.100 |
male | 120 | 91 | Â | 135 | 101 | Â | |
Serum AFP |  ≤ 20 ng/ml | 46 | 21 | 0.045 | 32 | 23 | 0.652 |
 > 20 ng/ml | 105 | 88 |  | 122 | 103 |  | |
Virus infection | HBV | 108 | 84 | 0.523 | 119 | 106 | 0.406 |
HCV | 14 | 11 | Â | 11 | 8 | Â | |
HBV + HCV | 9 | 3 |  | 11 | 4 |  | |
none | 20 | 11 | Â | 13 | 8 | Â | |
Cirrrhosis | absent | 40 | 32 | 0.674 | 42 | 34 | 1.000 |
present | 111 | 77 | Â | 112 | 92 | Â | |
Child–pugh score | Class A | 113 | 83 | 0.884 | 130 | 103 | 0.630 |
Class B | 38 | 26 | Â | 24 | 23 | Â | |
Tumor number | single | 91 | 63 | 0.703 | 124 | 86 | 0.026 |
multiple | 60 | 46 | Â | 30 | 40 | Â | |
Maximal tumor size |  ≤ 5 cm | 69 | 39 | 0.126 | 102 | 56 |  < 0.001 |
 > 5 cm | 82 | 70 |  | 52 | 70 |  | |
Tumor encapsulation | present | 95 | 50 | 0.008 | 118 | 77 | 0.006 |
absent | 56 | 59 | Â | 36 | 49 | Â | |
Microvascular invasion | absent | 97 | 45 |  < 0.001 | 97 | 56 | 0.003 |
present | 54 | 64 | Â | 57 | 70 | Â | |
Tumor differentiation | I-II | 131 | 75 | 0.001 | 132 | 77 |  < 0.001 |
III-IV | 20 | 34 | Â | 22 | 49 | Â | |
TNM stage | I-II | 128 | 70 |  < 0.001 | 136 | 82 |  < 0.001 |
III | 23 | 39 | Â | 18 | 44 | Â |